Vertex Pharmaceuticals, Inc. (VRTX)
477.92
+19.11
(+4.17%)
USD |
NASDAQ |
Feb 06, 16:00
476.19
-1.73
(-0.36%)
After-Hours: 20:00
Vertex Pharmaceuticals SG&A Expense (TTM) : 1.644B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Eli Lilly & Co. | 11.09B |
| Merck & Co., Inc. | 10.73B |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Moderna, Inc. | 1.061B |